Group 1 - The company has obtained the drug production registration approval from the National Medical Products Administration (NMPA) for Levofloxacin Eye Drops (0.488% (5ml: 24.4mg)), classified as a Class 4 chemical drug, which is considered to have passed the consistency evaluation [1][2] - Levofloxacin Eye Drops are primarily used for treating eyelid inflammation, meibomian gland inflammation, dacryocystitis, conjunctivitis, meibomian gland inflammation, keratitis, and for sterile chemotherapy during ophthalmic surgeries, enriching the company's ophthalmic product portfolio [1][2] - The company has also announced the approval for Compound Magnesium Sulfate Granules (10mg per bag), classified as a Class 3 chemical drug, which is also considered to have passed the consistency evaluation [1][2] Group 2 - Compound Magnesium Sulfate Granules are mainly used for bowel cleansing preparation before colonoscopy and X-ray examinations, and can also be used for bowel cleansing before surgical procedures [1][2] - The company's magnesium sulfate active pharmaceutical ingredient has been registered with the NMPA for use in marketed formulations, as noted in the announcement dated December 4, 2025 [1][2]
石四药集团(02005)取得国家药监局有关左氧氟沙星滴眼液的药品生产注册批件